(Image: DOST PCHRD)
• Studies have shown that the effectiveness of treatment and therapy may vary based on genetic differences.
• DOST and PCHRD are investing in omic technology, which will allow local scientists to conduct medical research tailored for Filipinos.
• Omic technology will benefit not just the medical field, but other sectors as well.
Despite what we may have been conditioned to think, medical research isn’t a one-size-fits-all proposition.
Research has shown that the effectiveness of medicine and therapy may vary depending on patients’ race, diet, and environment, among other factors. Medicine made for Americans or Europeans, for example, are unlikely to be as effective if they’re used by Filipinos.
To solve this, medicine and therapy options must be tailored to suit the traits and needs of people living in a particular country. However, this requires a combination of enough data and the right facilities.